In briefing documents for the meeting, the FDAs experts say there is a lack of evidence on effectiveness and safety to justify letting pharmacies make the peptides that the panel will review
Important Notice: These products are not classified as food supplements or medicines
Reduced Inflammation: Hence, the anti-inflammatory property of these peptides should be further investigated to understand some of their potent mechanisms in managing chronic inflammatory conditions and general tissue health
The exact product, concentration, route, and quantity should follow clinician directions
Any laboratory claiming to offer nasal spray testing should be assessed against its capability to perform the full OINDP testing battery, not just generic pharmaceutical chemistry and microbiology
Our semaglutide syringe conversion chart covers the most common compounded concentrations in detail